Organic nitrates and method for their preparation
AssigneeSchwarz Pharma AG
InventorsKlaus Sandrock, Joachim Hutter, Eike Noack
Life of this patent
Estimating the term…
Abstract
New organic nitrate compounds, formed by condensing a nitrato alkanoic acid with a sulfur-containing amino acid or peptide, which prevent nitrate tolerance or overcome existing tolerance and which are useful for the treatment of cardiac diseases including circulatory diseases, high blood pressure, cardiac insufficiency and for dilating the peripheral vessels.
Claims18
Compounds of the formula ##STR6## wherein:
- R represents hydroxy, lower alkoxy, lower alkenoxy, di-lower alkylamino-lower alkoxy, acylamino-lower alkoxy, acyloxy-lower alkoxy, aryloxy, aryl-lower alkyloxy, substituted aryloxy or substituted aryl-lower alkoxy groups, where the substituent is a member of the group consisting of methyl, methoxy and halogen;
- amino, lower alkylamino, di-lower alkylamino, aryl-lower alkylamino, hydroxy-lower alkylamino or amino acid groups through peptide bonds,
- R.sup.1 represents hydrogen, alkyl with 1 to 6 carbon atoms, substituted lower alkyl, where the substituent is a member of the group consisting of halogen, groups defined by R containing hydroxy, lower alkoxy, aryloxy, amino, lower alkylamino, acylamino, acyloxy, arylamino, mercapto, lower alkylthio and arylthio,
- R.sup.2 represents hydrogen, lower alkyl and the groups represented by R.sup.1,
- R.sup.3 represents hydrogen and lower alkyl,
- R.sup.4 represents hydrogen, lower alkyl, phenyl, methoxyphenyl, phenyl-lower alkyl, methoxyphenyl-lower alkyl, hydroxyphenyl-lower alkyl, hydroxy lower alkyl, alkoxy lower alkyl, amino-lower alkyl, acylamino lower alkyl, mercapto-lower alkyl and lower alkylthio-lower alkyl,
- R.sup.5 represents lower alkylthiol, --SH and S-acyls of alkylthiol and --SH and particularly --S-acetyl, --S-propionyl, --S-butyryl, --S-isobutyryl, --S-caproyl, --S-capryl, --S-pivaloyl and --S-benzoyl, lower alkyl --S--C--O--R.sup.6, lower alkyl --S--C--N--R.sup.6, lower alkylthio-lower alkanoic acid and esters and amides thereof, and lower alkylthio-lower alkyl, wherein R.sup.6 represents hydrogen and lower alkyl,
- groups in which R and R.sup.5 are bonded together and form part of a thiolactone group,
- m, n and q are whole numbers from 0 to 10,
- p is 0 or 1, and
- pharmaceutically acceptable salts thereof.
A pharmaceutical composition in unit dosage form comprising as an active ingredient about 1 to 500 mg per unit dosage form of a compound of the group consisting of N-(3-nitratobutyryl)-cysteine;
- N-(3-nitratobutyryl)methionine;
- N-(3-nitratopivaloyl)-cysteine;
- N-(3-nitratopivaloyl)-methionine and lower alkyl esters thereof, and a nontoxic solid pharmaceutical carrier.
Dependencies are inferred from the claim text.